Evidence map›Paper›PMID 32871179›Full record

ArticleThe Journal of infection2021

Viral transmission in asymptomatic cases of SARS-CoV-2 infection.

Isabelle Grall, Chakib-Ahmed Alloui, Yacine Tandjaoui-Lambiotte, Antoine Deslandes, Delphine Seytre, Julie Chappe, Etienne Carbonnelle, Segolène Brichler, Anne Jacolot, Jean-Ralph Zahar and 1 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of infection, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Isabelle GrallCentre de Médecine Physique et de Réadaptation, 93000 Bobigny Cedex, France; Université de Paris, IAME, INSERM, UMR 1137, F-75018 Paris, France; Université Sorbonne Paris Nord, F-93000 Bobigny, France; AP-HP, Hôpital Avicenne, service de Microbiologie Clinique, F-93000 Bobigny, France.
Chakib-Ahmed AllouiCentre de Médecine Physique et de Réadaptation, 93000 Bobigny Cedex, France; Université de Paris, IAME, INSERM, UMR 1137, F-75018 Paris, France; Université Sorbonne Paris Nord, F-93000 Bobigny, France; AP-HP, Hôpital Avicenne, service de Microbiologie Clinique, F-93000 Bobigny, France.
Yacine Tandjaoui-LambiotteCentre de Médecine Physique et de Réadaptation, 93000 Bobigny Cedex, France; Université de Paris, IAME, INSERM, UMR 1137, F-75018 Paris, France; Université Sorbonne Paris Nord, F-93000 Bobigny, France; AP-HP, Hôpital Avicenne, service de Microbiologie Clinique, F-93000 Bobigny, France.
Antoine DeslandesCentre de Médecine Physique et de Réadaptation, 93000 Bobigny Cedex, France; Université de Paris, IAME, INSERM, UMR 1137, F-75018 Paris, France; Université Sorbonne Paris Nord, F-93000 Bobigny, France; AP-HP, Hôpital Avicenne, service de Microbiologie Clinique, F-93000 Bobigny, France.
Delphine SeytreCentre de Médecine Physique et de Réadaptation, 93000 Bobigny Cedex, France; Université de Paris, IAME, INSERM, UMR 1137, F-75018 Paris, France; Université Sorbonne Paris Nord, F-93000 Bobigny, France; AP-HP, Hôpital Avicenne, service de Microbiologie Clinique, F-93000 Bobigny, France.
Julie ChappeCentre de Médecine Physique et de Réadaptation, 93000 Bobigny Cedex, France; Université de Paris, IAME, INSERM, UMR 1137, F-75018 Paris, France; Université Sorbonne Paris Nord, F-93000 Bobigny, France; AP-HP, Hôpital Avicenne, service de Microbiologie Clinique, F-93000 Bobigny, France.
Etienne CarbonnelleCentre de Médecine Physique et de Réadaptation, 93000 Bobigny Cedex, France; Université de Paris, IAME, INSERM, UMR 1137, F-75018 Paris, France; Université Sorbonne Paris Nord, F-93000 Bobigny, France; AP-HP, Hôpital Avicenne, service de Microbiologie Clinique, F-93000 Bobigny, France.
Segolène BrichlerCentre de Médecine Physique et de Réadaptation, 93000 Bobigny Cedex, France; Université de Paris, IAME, INSERM, UMR 1137, F-75018 Paris, France; Université Sorbonne Paris Nord, F-93000 Bobigny, France; AP-HP, Hôpital Avicenne, service de Microbiologie Clinique, F-93000 Bobigny, France.
Anne JacolotCentre de Médecine Physique et de Réadaptation, 93000 Bobigny Cedex, France; Université de Paris, IAME, INSERM, UMR 1137, F-75018 Paris, France; Université Sorbonne Paris Nord, F-93000 Bobigny, France; AP-HP, Hôpital Avicenne, service de Microbiologie Clinique, F-93000 Bobigny, France.
Jean-Ralph ZaharCentre de Médecine Physique et de Réadaptation, 93000 Bobigny Cedex, France; Université de Paris, IAME, INSERM, UMR 1137, F-75018 Paris, France; Université Sorbonne Paris Nord, F-93000 Bobigny, France; AP-HP, Hôpital Avicenne, service de Microbiologie Clinique, F-93000 Bobigny, France. Electronic address: jeanralph.zahar@aphp.fr.
Alexandra LomontCentre de Médecine Physique et de Réadaptation, 93000 Bobigny Cedex, France; Université de Paris, IAME, INSERM, UMR 1137, F-75018 Paris, France; Université Sorbonne Paris Nord, F-93000 Bobigny, France; AP-HP, Hôpital Avicenne, service de Microbiologie Clinique, F-93000 Bobigny, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Asymptomatic InfectionsAgedAged, 80 and overCOVID-19FemaleHumansMaleMiddle Aged

Identifiers

PMID32871179
PMCPMC7834248

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.